Skip to main content
. 2019 Mar 18;120(8):791–796. doi: 10.1038/s41416-019-0428-3

Fig. 3.

Fig. 3

Decrease in mutant allele fraction from plasma cell-free DNA during afatinib–dasatinib treatment. Patients with activating epidermal growth factor receptor mutations had paired samples assessed by digital droplet polymerase chain reaction. Fifteen patients were evaluable. Bars represent mean values with 95% confidence intervals. *P < .05 by Wilcoxon matched-pairs signed-rank test